Xuejun Xia
Impact in
- Pharmaceutical Science top 2%
- Advanced Drug Delivery Systems
- Advancements in Transdermal Drug Delivery
- Drug Solubulity and Delivery Systems
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
Papers in
-
- RNA Interference and Gene Delivery 10
- Advanced biosensing and bioanalysis techniques 3
-
- Advancements in Transdermal Drug Delivery 9
- Advanced Drug Delivery Systems 9
- Co-authors
- Yuling Liu (21 shared papers)Wujun Dong (18 shared papers)Yanfang Yang (17 shared papers)Jun Ye (16 shared papers)Cuiping Zhou (3 shared papers)Yuling Liu (10 shared papers)Hongliang Wang (10 shared papers)Liyao Liu (1 shared paper)
In The Last Decade
Xuejun Xia
41 papers receiving 990 citations
Peers
Comparison fields: 5 of 108
- Pharmaceutical Science 220
- Biomaterials 261
- Molecular Medicine 32
- Molecular Biology 389
- Pharmacology 46
Countries citing papers authored by Xuejun Xia
This map shows the geographic impact of Xuejun Xia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuejun Xia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuejun Xia more than expected).
Fields of papers citing papers by Xuejun Xia
This network shows the impact of papers produced by Xuejun Xia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuejun Xia. The network helps show where Xuejun Xia may publish in the future.
Co-authors
The 25 scholars most cited alongside Xuejun Xia, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 44 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 98 | |
| 2 | 2016 | 95 | |
| 3 | 2019 | 67 | |
| 4 | 2019 | 64 | |
| 5 | 2015 | 64 | |
| 6 | 2016 | 50 | |
| 7 | 2018 | 43 | |
| 8 | 2019 | 42 | |
| 9 | 2016 | 36 | |
| 10 | 2015 | 35 | |
| 11 | 2018 | 30 | |
| 12 | 2020 | 28 | |
| 13 | 2016 | 27 | |
| 14 | 2015 | 25 | |
| 15 | 2012 | 24 | |
| 16 | 2017 | 23 | |
| 17 | 2016 | 23 | |
| 18 | 2021 | 23 | |
| 19 | 2011 | 22 | |
| 20 | 2017 | 22 |
About Xuejun Xia
Xuejun Xia is a scholar working on Molecular Biology, Pharmaceutical Science, Biomaterials, Biomedical Engineering and Oncology, having authored 44 papers that have together received 1.0k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (10 papers), Nanoparticle-Based Drug Delivery (9 papers), Advancements in Transdermal Drug Delivery (9 papers), Advanced Drug Delivery Systems (9 papers), Nanoplatforms for cancer theranostics (5 papers), Cancer Treatment and Pharmacology (4 papers), Inhalation and Respiratory Drug Delivery (3 papers) and Advanced biosensing and bioanalysis techniques (3 papers). The work is most often cited by research in Pharmaceutical Science (220 citations), Biomaterials (261 citations), Molecular Medicine (32 citations), Molecular Biology (389 citations) and Pharmacology (46 citations). Xuejun Xia has collaborated with scholars based in China and Czechia. Frequent co-authors include Yuling Liu, Wujun Dong, Yanfang Yang, Jun Ye, Cuiping Zhou, Yuling Liu, Hongliang Wang, Liyao Liu, Panpan Ma and Lin Li. Their work appears in journals such as Pharmaceutics, Molecules, International Journal of Nanomedicine, Journal of Controlled Release and Frontiers in Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.